Alpha -Tocopherol Ascorbic Acid Beta Carotene Biot

證據等級: L5

預測適應症: 0 個

Multivitamin/Multimineral Combination: Insufficient Data for Repurposing Evaluation

One-Sentence Summary

This candidate is a 16-ingredient multivitamin and multimineral combination (including α-Tocopherol, Ascorbic Acid, Beta Carotene, Cholecalciferol, Cyanocobalamin, Folic Acid, and others), with no approved indication documented and no US market authorization. The TxGNN model did not generate any predicted new indications for this combination — most likely because the multi-ingredient formula could not be mapped to a single DrugBank entity, which is a prerequisite for the model’s knowledge graph traversal. This candidate cannot be evaluated for drug repurposing potential until the underlying data gaps are resolved.

Quick Overview

Item	Content
Original Indication	None documented
Predicted New Indication	None — no TxGNN predictions generated
TxGNN Prediction Score	N/A
Evidence Level	N/A
US Market Status	Not marketed
Number of NDAs	0
Recommended Decision	Hold

Why This Candidate Could Not Be Evaluated

TxGNN operates by traversing a biomedical knowledge graph in which each drug is represented as a single node mapped to a DrugBank ID. This candidate contains 16 distinct active ingredients:

α-Tocopherol · Ascorbic Acid · Beta Carotene · Biotin · Cholecalciferol · Cupric Oxide · Cyanocobalamin · Folic Acid · Levomefolate Glucosamine · Niacinamide · Pyridoxine · Riboflavin · Sodium Fluoride · Thiamine · Vitamin A Acetate · Zinc Gluconate

Because the combination lacks a unified DrugBank ID (drugbank_id: null), TxGNN was unable to locate a corresponding graph node and therefore produced zero repurposing predictions. This is a structural limitation of how multi-ingredient supplements are represented in DrugBank — not a signal that the ingredients lack therapeutic interest individually.

Each ingredient is, in fact, a well-characterized micronutrient with known mechanisms. For example:

Ascorbic Acid (Vitamin C) — antioxidant, collagen synthesis cofactor
Cholecalciferol (Vitamin D3) — calcium homeostasis, immune modulation
Cyanocobalamin (Vitamin B12) — DNA synthesis, neurological function
Folic Acid / Levomefolate — one-carbon metabolism, neural tube development

To unlock repurposing analysis, this combination must be decomposed into individual ingredients and each evaluated independently against TxGNN.

Safety Considerations

Please refer to the package insert for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: No TxGNN predictions were generated because the multi-ingredient formula lacks a DrugBank ID. Without predicted indications, clinical trial evidence, or an approved indication to anchor the analysis, repurposing evaluation cannot proceed for this candidate as currently defined.

To proceed, the following is needed:

Decompose the combination into individual active ingredients and obtain DrugBank IDs for each (e.g., Ascorbic Acid → DB00126, Cholecalciferol → DB00169, Cyanocobalamin → DB00115)
Re-run TxGNN predictions for each ingredient separately, then aggregate results by ingredient
Clarify the intended product — determine whether this is a specific branded formulation (e.g., prenatal vitamin, ophthalmic supplement such as AREDS formula) to establish the clinical context
Obtain MOA and safety data from DrugBank for key active ingredients to support mechanistic analysis
Confirm US regulatory status — verify whether any branded product containing this exact combination holds an NDA, OTC monograph approval, or DSHEA dietary supplement notification
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.